Wells Fargo & Company Invo Bioscience, Inc. Transaction History

Wells Fargo & Company

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$0.16 - $0.64 $2 - $9	15 Added 19.74%	91 $0
Q1 2023 May 12, 2023	BUY	$0.44 - $0.81 $0 - $0	1 Added 1.33%	76 $0
Q4 2022 Feb 13, 2023	BUY	$0.39 - $28.0 $1 - $84	3 Added 4.17%	75 $0
Q2 2022 Aug 12, 2022	SELL	$0.64 - $2.66 $54 - $226	-85 Reduced 54.14%	72 $0
Q1 2022 May 16, 2022	BUY	$2.19 - $3.82 $203 - $355	93 Added 145.31%	157 $0
Q4 2021 Feb 14, 2022	BUY	$2.93 - $4.19 $20 - $29	7 Added 12.28%	64 $0
Q3 2021 Nov 15, 2021	BUY	$3.17 - $4.61 $9 - $13	3 Added 5.56%	57 $0
Q2 2021 Aug 16, 2021	BUY	$3.71 - $5.18 $14 - $20	4 Added 8.0%	54 $0
Q4 2020 Feb 09, 2021	BUY	$3.0 - $9.47 $150 - $473	50 New	50 $0

14.1K

Ticker INVO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,169,700
Market Cap $9.86M
Description
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.